Persistance of HBsAg and serum activities of liver enzymes among chronic carriers of hepatitis B

Authors

Mansoure Momen heravi1,*, Hossein Akbari2
1Asistant professor of infectious diseases, Kashan University of Medical Sciences and Health Services, Kashan, Iran
2Instructor of Biostatistics, School of Health, Kashan University of Medical Sciences and Health Services, Kashan, Iran.
*Corresponding Author: Asistant professor of infectious diseases, Kashan University of Medical Sciences and Health Services, Kashan, Iran Email: [email protected]

Zahedan Journal of Research in Medical Sciences:Vol. 13, issue 3; e94013
Published online:Jan 01, 2011
Article type:Research Article
Received:Apr 13, 2010
Accepted:Oct 19, 2010
How to Cite:Momen heravi M, Akbari H. Persistance of HBsAg and serum activities of liver enzymes among chronic carriers of hepatitis B. Zahedan J Res Med Sci. 2011;13(3):e94013. doi:

Abstract

Background:  Hepatitis B virus (HBV) infection and its squeals are major global health problems. This study was conducted to evaluate HBsAg persistence, risk factors of HBV infection and changes of liver function tests among chronic HBV carriers in Kashan.

Materials and Method: This descriptive study was performed in HBsAg positive blood donors who detected after blood donation since 10 years ago. They were requested to retest HBsAg. A questionnaire consisting demographic and history of risk factors of HBV infection were filled by interviewing and then blood was taken for HBsAg test. Who had HBsAg positive test HBeAg, liver function tests were measured. The results were analyzed χ2, Fisher exact and t-tests using SPSS-13 software.

Results: A total of 150 HBsAg positive blood donors persistence of HBsAg in 88% and clearance was seen in 12% of cases. There was no significant statistical correlation between risk factors of HBV infection, with persistence of HBsAg.

HBeAg was positive in 18.2% of HBsAg positive cases. There was no statistical correlation between ALT, AST and ALP with HBeAg. Chronic hepatitis B infection was detected in three patients.

Conclusion: Considering the lower rate of clearance of HBsAg and detecting cases of chronic hepatitis periodic examination of liver function tests seems to be essential in follow up in chronic HBV carriers

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

4
Nov
2019
HBV DNA in the Plasma and Peripheral Blood Mononuclear Cells in Chronic HBV Infected Individuals Who Became HBsAg-Serocleared or Seroconverted

HBV DNA in the Plasma and Peripheral Blood Mononuclear Cells in Chronic HBV Infected Individuals Who Became HBsAg-Serocleared or Seroconverted

Jila Masrour-Roudsari,
Mohammad Reza Hasanjani Roushan,
Yousef Yahyapour,
Ali Bijani,
Farzin Sadeghi

Masrour-Roudsari J, Hasanjani Roushan MR, Yahyapour Y, Bijani A, Sadeghi F. HBV DNA in the Plasma and Peripheral Blood Mononuclear Cells in Chronic HBV Infected Individuals Who Became HBsAg-Serocleared or Seroconverted. Hepat Mon. 2019;19(11):e96014. doi: https://doi.org/10.5812/hepatmon.96014

10
Apr
2016

Survey the hepatitis B serologic markers in patients referred to the clinic of Kermanshah University of Medical Sciences

Alisha Akya,
Mehrdad Khodadoost,
Farzaneh Mohebi,
Milad Dehghani,
Maryam Amighi

Akya A, Khodadoost M, Mohebi F, Dehghani M, Amighi M. Survey the hepatitis B serologic markers in patients referred to the clinic of Kermanshah University of Medical Sciences. J Clin Res Paramed Sci. 2016;5(1):e81441. doi:

5
Feb
2014

How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?

Maryam Keshvari,
Seyed Moayed Alavian,
Heidar Sharafi

Keshvari M, Alavian SM, Sharafi H. How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?. Hepat Mon. 2014;14(2):e15285. doi: https://doi.org/10.5812/hepatmon.15285

8
Mar
2017

Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection

Ergenekon Karagoz,
Alpaslan Tanoglu

Karagoz E, Tanoglu A. Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection. Hepat Mon. 2017;17(4):e12293. doi: https://doi.org/10.5812/hepatmon.36112

28
Dec
2016

Follow-Up of Chronic Hepatitis B Carriers: A Cross-Sectional Descriptive-Analytical Study

Tahereh Darvishpoor Kakhki,
Bita Bigari,
Ghodsiyeh Azarkar,
Masood Ziaee

Darvishpoor Kakhki T, Bigari B, Azarkar G, Ziaee M. Follow-Up of Chronic Hepatitis B Carriers: A Cross-Sectional Descriptive-Analytical Study. Mod Care J. 2017;14(1):e64726. doi: https://doi.org/10.5812/modernc.64726

More by these authors

Mansoure Momen heraviPubMedScholar
Hossein AkbariPubMedScholar
Share
Cited by
Metrics